UPC_CFI_165/2024

PROCESS FOR CONCENTRATION OF ANTIBODIES AND THERAPEUTIC PRODUCTS THEREOF

Provisional measuresProvisional MeasuresDusseldorf LDProvisional measuresCase Closed

This case cites

Authorities cited within the decisions on file for this case.

Target	Legal point	Strength	Excerpt
Art. 25 UPCA	uniform substantive patent law; direct infringement	Binding	Art. 25 UPCA constitutes uniform substantive law and Art. 62 (1) UPCA uniform procedural law, which takes precedence over national patent laws
Art. 62 UPCA	provisional measures; uniform procedural law	Binding	Art. 25 UPCA constitutes uniform substantive law and Art. 62 (1) UPCA uniform procedural law, which takes precedence over national patent laws

Target	Legal point	Strength	Excerpt
RoP_rule 295	stay of proceedings not applicable to provisional measures applications	Binding	Rule R. 295 RoP (stay of proceedings) refers to actions and is therefore not applicable to applications for provisional measures.
RoP_rule 213	provisional measures; requirements for granting	Binding	measures according to the clear wording of Rule 213.1 RoP.

Cited by

Subsequent UPC decisions citing this case.

Cited in	Date	Legal point	Strength	Excerpt
UPC_CFI_662/2025 Mannheim LD	Nov 3, 2025	commercial relationship for jurisdiction	Persuasive	Lokalkammer Düsseldorf, Anordnung v. 06. September 2024, UPC CFI 165/2024, ACT_18492/2024 - Novartis/Celltrion